Generate a tailored SOP for Dr. Sarah Davidson. Improve your application with a focused, well-structured draft.
Sarah Davidson is an Adjunct Associate Lecturer in the School of Biomedical Sciences at the University of New South Wales, having joined the Therapeutic Vaccine Research Program at the Kirby Institute in 2018. With over ten years of experience in Clinical Haematology Research, she has developed expertise in the investigation of therapeutic approaches for blood disorders. Currently, Sarah is focused on research projects that explore the effectiveness of DNA incorporation of azacitidine derivatives in mononuclear cells, particularly comparing treatment durations of oral azacitidine over 21 days versus 7 days of Vidaza® in a 28-day treatment cycle. Her contributions to the field are grounded in rigorous scientific methodology and a commitment to advancing clinical research in hematology.
Includes Business Intelligence, Enterprise Systems, and Cybersecurity Management streams.